Sickle Cell Disease Treatment Demonstration Program Regional Collaborative

Funding Opportunity Number: HRSA-14-078 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.365Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-HRSAClosing Date: May 27, 2014Award Ceiling: $850,000Expected Number of Awards: 4Creation Date: Apr 24, 2014Funding Opportunity Description: This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative.? The purpose of this funding opportunity is to: (1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease. ?This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the ...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding